Avitia

Avitia is an AI company providing end-to-end testing solutions to rapidly identify cancer mutations and applicable treatments. Its platform empowers labs and oncologists to accelerate targeted treatments, reduce costs, and improve patient-focused care. The company's technology allows for advanced molecular testing directly on-site, offering a cost-effective alternative to existing send-out methods.

Funding Round: Seed

Funding Amount: $5M

Date: 27-Feb-2025

Investors: PacBridge Capital Partners

Markets: Healthtech, AI, Biotechnology, Oncology

HQ: Montreal, Canada

Founded: 2024

Website: https://www.avitia.bio

LinkedIn: https://www.linkedin.com/company/avitia-bio

Twitter: https://twitter.com/avitiabio

Instagram:

Facebook: https://www.facebook.com/avitiabio